Dr. Sharad Adekar is a Physician Scientist with clinical experience in Family Practice and Pediatrics, and research experience in Immunology, Oncology, Infectious diseases, and Neurology. Currently, he is working as Medical Chair at WCG, Puyallup, WA since November 2013. Prior starting at WCG, Dr. Adekar was working as Consultant in Antibody discovery and development areas. He also worked as Director of Antibody research at Immunome, Inc. in Pennsylvania. He received his medical degree (M.B.B.S., MD) from B.J. Medical College, Pune and worked on his Ph.D. thesis (Development and characterization of native human monoclonal antibodies against botulinum toxin) at Thomas Jefferson University, Philadelphia, PA and received PhD from University of Pune, India. Dr. Adekar has invented a novel method to make human monoclonal antibodies and received US patent for ‘Fusion partner cell line that are used for preparation of hybrid cells that express human antibodies’ in October 2013 and ‘Method of making hybrid cells that express useful antibodies’ in April 2015. Dr. Adekar has extensive experience in human antibodies in terms of discovery, lead optimization and preclinical development of monoclonal antibody therapeutics. He has developed human monoclonal antibodies against cancer antigens, vaccinia virus, polio virus, rabies virus, influenza virus, botulinum neuro-toxin, clostridium difficile toxin and amyloid peptides in Alzheimer’s disease. He has published various peer-reviewed articles and participated in several conference presentations that include panel discussions, invited presentations as well as peer-reviewed oral presentations.